BioNTech SE (NASDAQ: BNTX) stock closed at 112.75 per share at the end of the most recent trading day (a 3.78% change compared to the prior day closing price) with a volume of 1.11M shares and market capitalization of 27.17B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1310 people. BioNTech SE CEO is Ugur Sahin.

The one-year performance of BioNTech SE stock is -19.45%, while year-to-date (YTD) performance is -24.94%. BNTX stock has a five-year performance of %. Its 52-week range is between 95.5 and 188.985, which gives BNTX stock a 52-week price range ratio of 18.45%

BioNTech SE currently has a PE ratio of 3.70, a price-to-book (PB) ratio of 1.89, a price-to-sale (PS) ratio of 2.83, a price to cashflow ratio of 3.00, a PEG ratio of -, a ROA of 52.31%, a ROC of 74.73% and a ROE of 72.05%. The company’s profit margin is 54.91%, its EBITDA margin is 78.80%, and its revenue ttm is $12.77 Billion , which makes it $52.64 revenue per share.

Of the last four earnings reports from BioNTech SE, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.92 for the next earnings report. BioNTech SE’s next earnings report date is 06th Nov 2023.

The consensus rating of Wall Street analysts for BioNTech SE is Moderate Buy (2.09), with a target price of $217.6, which is +92.99% compared to the current price. The earnings rating for BioNTech SE stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioNTech SE has a dividend yield of 1.03% with a dividend per share of $1.53 and a payout ratio of -%.

BioNTech SE has a Neutral technical analysis rating based on Technical Indicators (ADX : 14.03, ATR14 : 3.55, CCI20 : -1.39, Chaikin Money Flow : -0.07, MACD : -2.26, Money Flow Index : 32.30, ROC : -0.93, RSI : 53.79, STOCH (14,3) : 69.50, STOCH RSI : 1.00, UO : 56.15, Williams %R : -30.50), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioNTech SE in the last 12-months were: